108 related articles for article (PubMed ID: 26512078)
21. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.
Kim YI; Song JH; Kwon BE; Kim HN; Seo MD; Park K; Lee S; Yeo SG; Kweon MN; Ko HJ; Chang SY
Vaccine; 2015 Nov; 33(48):6604-10. PubMed ID: 26529069
[TBL] [Abstract][Full Text] [Related]
22. Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
Kelly JT; De Colibus L; Elliott L; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
Antiviral Res; 2015 Dec; 124():77-82. PubMed ID: 26522770
[TBL] [Abstract][Full Text] [Related]
23. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines.
Ng Q; He F; Kwang J
Viruses; 2015 Dec; 7(12):6441-57. PubMed ID: 26670245
[TBL] [Abstract][Full Text] [Related]
24. Biological characteristics of different epidemic enterovirus 71 strains and their pathogeneses in neonatal mice and rhesus monkeys.
Zhongping X; Hua L; Ting Y; Zhengling L; Min F; Tianhong X; Runxiang L; Dong S; Guangju J; Lei Y; Rong Y; Fangyu L; Qihan L
Virus Res; 2016 Feb; 213():82-89. PubMed ID: 26555165
[TBL] [Abstract][Full Text] [Related]
25. Enterovirus D-68: an emerging cause of infection.
Principi N; Esposito S
Expert Rev Respir Med; 2015; 9(6):711-9. PubMed ID: 26535922
[TBL] [Abstract][Full Text] [Related]
26. Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication.
Fu Y; Xu W; Chen D; Feng C; Zhang L; Wang X; Lv X; Zheng N; Jin Y; Wu Z
Antiviral Res; 2015 Dec; 124():43-53. PubMed ID: 26515789
[TBL] [Abstract][Full Text] [Related]
27. Sialic acid-dependent cell entry of human enterovirus D68.
Liu Y; Sheng J; Baggen J; Meng G; Xiao C; Thibaut HJ; van Kuppeveld FJ; Rossmann MG
Nat Commun; 2015 Nov; 6():8865. PubMed ID: 26563423
[TBL] [Abstract][Full Text] [Related]
28. Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses.
Kang H; Kim C; Kim DE; Song JH; Choi M; Choi K; Kang M; Lee K; Kim HS; Shin JS; Kim J; Han SB; Lee MY; Lee SU; Lee CK; Kim M; Ko HJ; van Kuppeveld FJ; Cho S
Antiviral Res; 2015 Dec; 124():1-10. PubMed ID: 26526589
[TBL] [Abstract][Full Text] [Related]
29. RISK FACTORS FOR SEVERE HAND, FOOT AND MOUTH DISEASE.
Owatanapanich S; Wutthanarungsan R; Jaksupa W; Thisyakorn U
Southeast Asian J Trop Med Public Health; 2015 May; 46(3):449-59. PubMed ID: 26521518
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of DAP5 by coxsackievirus B3 2A protease facilitates viral replication and enhances apoptosis by altering translation of IRES-containing genes.
Hanson PJ; Ye X; Qiu Y; Zhang HM; Hemida MG; Wang F; Lim T; Gu A; Cho B; Kim H; Fung G; Granville DJ; Yang D
Cell Death Differ; 2016 May; 23(5):828-40. PubMed ID: 26586572
[TBL] [Abstract][Full Text] [Related]
31. Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5' Untranslated Region.
Muslin C; Joffret ML; Pelletier I; Blondel B; Delpeyroux F
PLoS Pathog; 2015; 11(11):e1005266. PubMed ID: 26562151
[TBL] [Abstract][Full Text] [Related]
32. Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013.
Hassel C; Mirand A; Lukashev A; TerletskaiaLadwig E; Farkas A; Schuffenecker I; Diedrich S; Huemer HP; Archimbaud C; Peigue-Lafeuille H; Henquell C; Bailly JL
Euro Surveill; 2015; 20(34):30005. PubMed ID: 26530407
[TBL] [Abstract][Full Text] [Related]
33. Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch.
Pearson FE; Muller DA; Roalfe L; Zancolli M; Goldblatt D; Kendall MA
Vaccine; 2015 Nov; 33(48):6675-83. PubMed ID: 26518398
[TBL] [Abstract][Full Text] [Related]
34. The Structure, Pathogenicity and Immunogenicity of Two Virion Fractions Harvested from Cell Cultures Infected with the CA16 Virus.
Pu J; Huang H; Zhang Y; Feng M; Yang E; Che Y; Dong C; Liao Y; Liu L; Wang L; Wang J; Li Q
Intervirology; 2015; 58(4):260-9. PubMed ID: 26517705
[TBL] [Abstract][Full Text] [Related]
35. A tradeoff between enterovirus A71 particle stability and cell entry.
Catching A; Te Yeh M; Bianco S; Capponi S; Andino R
Nat Commun; 2023 Nov; 14(1):7450. PubMed ID: 37978288
[TBL] [Abstract][Full Text] [Related]
36. Directed Evolution of Seneca Valley Virus in Tumorsphere and Monolayer Cell Cultures of a Small-Cell Lung Cancer Model.
Waqqar S; Lee K; Lawley B; Bilton T; Quiñones-Mateu ME; Bostina M; Burga LN
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174006
[TBL] [Abstract][Full Text] [Related]
37. Advances in anti-EV-A71 drug development research.
Wang S; Pang Z; Fan H; Tong Y
J Adv Res; 2024 Feb; 56():137-156. PubMed ID: 37001813
[TBL] [Abstract][Full Text] [Related]
38. 3,4-Dicaffeoylquinic Acid from the Medicinal Plant
Hsieh CF; Chen YL; Lin GH; Chan YF; Hsieh PW; Horng JT
J Virol; 2022 Apr; 96(7):e0054221. PubMed ID: 35319229
[TBL] [Abstract][Full Text] [Related]
39. Conserved Residues Adjacent to ß-Barrel and Loop Intersection among Enterovirus VP1 Affect Viral Replication: Potential Target for Anti-Enteroviral Development.
Huang YL; Huang SW; Shen CY; Cheng D; Wang JR
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215957
[No Abstract] [Full Text] [Related]
40. SAMHD1 Inhibits Multiple Enteroviruses by Interfering with the Interaction between VP1 and VP2 Proteins.
Zhao Z; Li Z; Huan C; Liu X; Zhang W
J Virol; 2021 Jun; 95(13):e0062021. PubMed ID: 33883225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
